Bandaram Pharma Packtech

46.37
+3.34
(7.76%)
Market Cap
55.61 Cr
EPS
0.43
PE Ratio
50.62
Dividend Yield
0.23 %
52 Week High
63.14
52 Week Low
28.31
PB Ratio
3.93
Debt to Equity
1.72
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,478.80
#1 20,720.72
50.13
#1 2,295.80
11.52
#1 362
19.34
43.44
1,007.20
10,337.53
72.42
568.60
20.11
120
35.77
47.60
1,564.55
8,023.19
53.44
1,216.80
4.59
129
15.38
34.43
679.65
3,601.70
42.34
581.30
8.63
70
29.25
36.44
787.90
2,544.11
34.57
636.40
25.65
57
49.23
52.38
1,616.75
1,387.61
29.87
86.70
25.47
32
58.82
37.91
242.42
771.15
#1 7.43
1,436.10
35.04
6
-1,081.25
49.93
369.90
262.59
21.80
63.00
#1 248.07
7
133.33
75.20
85.23
87.69
109.40
13.60
-8.11
-3
#1 142.86
51.49
120.15
83.73
66.60
36.90
6.34
1
0.00
43.10
Growth Rate
Revenue Growth
80.42 %
Net Income Growth
200.00 %
Cash Flow Change
-275.45 %
ROE
25.30 %
ROCE
81.05 %
EBITDA Margin (Avg.)
17.72 %

Quarterly Financial Results

Quarterly Financials
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
0
0
1
2
5
10
6
7
7
14
11
7
10
Expenses
0
0
1
2
5
10
5
7
7
13
11
6
9
EBITDA
0
0
0
0
1
1
1
1
1
1
1
1
1
Operating Profit %
0 %
0 %
-5 %
4 %
14 %
4 %
9 %
6 %
6 %
5 %
5 %
15 %
7 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
-0
-0
0
0
0
0
0
0
0
1
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
0
-0
-0
0
0
0
0
0
0
0
1
0
EPS in ₹
0.00
-0.03
-0.56
-0.85
1.45
0.57
0.57
0.05
0.05
0.16
0.15
0.31
-0.01

Balance Sheet

Balance Sheet
2023
2024
Total Assets
20
32
Fixed Assets
5
5
Current Assets
15
26
Capital Work in Progress
0
0
Investments
0
1
Other Assets
15
26
Total Liabilities
20
32
Current Liabilities
7
12
Non Current Liabilities
8
5
Total Equity
5
15
Reserve & Surplus
0
0
Share Capital
3
12

Cash Flow

Cash Flow
2023
2024
Net Cash Flow
-2
-0
Investing Activities
-5
-2
Operating Activities
-1
-4
Financing Activities
5
6

Share Holding

% Holding
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Jul 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
0.04 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
24.33 %
24.36 %
24.36 %
24.36 %
24.36 %
24.31 %
24.25 %
24.38 %
24.11 %
24.21 %
24.23 %
23.99 %
23.73 %
Others
0.63 %
0.60 %
0.60 %
0.60 %
0.60 %
0.65 %
0.74 %
0.61 %
0.88 %
0.78 %
0.76 %
1.00 %
1.26 %
No of Share Holders
0
4,160
4,402
4,158
4,143
4,151
4,261
4,273
4,262
4,337
4,425
4,634
4,767

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.1 0.1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.27 0.22 0.00

Corporate Action

Announcements

Closure of Trading Window4 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 14, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMMar 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 21, 2025
Notice For The 1St Extra-Ordinary General Meeting Of The Company For The Financial Year 2024-25 Scheduled To Be Held On Friday 14.03.2025 At 11.00 A.M. Through Video Conference / Other Audio-Visual MeFeb 20, 2025
Integrated Filing (Financial)Feb 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 14.02.2025Feb 14, 2025
Board Meeting Intimation for Considering The Un-Audited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended 31.12.2024 And Any Other Business With The Permission Of TFeb 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 15, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Dec 06, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Dec 05, 2024
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Dec 04, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Dec 04, 2024
Board Meeting Outcome for Results For The Quarter And Half Year Ended 30.09.2024Nov 14, 2024
Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended 30.09.2024Nov 02, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 24, 2024
Closure of Trading WindowSep 27, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 09, 2024
Reg. 34 (1) Annual Report.Sep 09, 2024
Annual General Meeting Scheduled To Be Held As On 27.09.2024Sep 05, 2024
Reg. 34 (1) Annual Report.Sep 05, 2024
Book Closure Intimation For AGMSep 05, 2024
Board Meeting Outcome for Board Meeting Outcome For Final DividendSep 04, 2024
Board Meeting Intimation for Dividend For FY 2023-24Aug 31, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Aug 21, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 21, 2024
Board Meeting Outcome for Outcome Of The Board MeetingAug 13, 2024
Results (Standalone And Consolidated) For The Quarter Ended 30.06.2024Aug 13, 2024
Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30.06.2024 And Any Other Matter With The Permission Of The ChairAug 06, 2024
Announcement under Regulation 30 (LODR)-DemiseJul 12, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 10, 2024
Closure of Trading WindowJun 29, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2024
Audited Financial Results For The Quarter Ended 31.03.2024May 29, 2024
Board Meeting Intimation for AUDITED FINANCIAL RESULTSMay 14, 2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 23, 2024
Disclosure Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015Apr 19, 2024
Compliance Certificate Under Regulation 7(3) Of SEBI LODR Regulations, 2015Apr 16, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 16, 2024
Closure of Trading WindowMar 29, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateMar 27, 2024
Board Meeting Outcome for Outcome For Internal Auditor AppointmentMar 20, 2024
Clarification On Price MovementMar 20, 2024
Clarification sought from Bandaram Pharma Packtech LtdMar 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2024
Board Meeting Outcome for Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 31.12.2023Feb 12, 2024
Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 31.12.2023Feb 12, 2024
Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 31.12.2023.Feb 03, 2024

Technical Indicators

RSI(14)
Neutral
50.58
ATR(14)
Volatile
4.00
STOCH(9,6)
Neutral
45.53
STOCH RSI(14)
Neutral
35.09
MACD(12,26)
Bearish
-0.17
ADX(14)
Strong Trend
46.52
UO(9)
Bearish
51.16
ROC(12)
Downtrend And Accelerating
-2.99
WillR(14)
Neutral
-46.70